Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Table 2

Inclusion and exclusion criteria.

Inclusion criteria	(i) Aged 18–65 years, either sex
	(ii) Agreed with study and signed informed consent
	(iii) Clinical diagnosis of FD, according to functional dyspepsia criteria
	(iv) Stopped administrating prokinetic drugs, gastric mucosa protectant and hydrotalcite in the past 28 days
Exclusion criteria	(i) Patients with oesophagitis, atrophic gastritis, gastric and duodenum ulcers
	(ii) Patients with liver, gallbladder, pancreas organic diseases
	(iii) Patients with diabetes, kidney diseases, connective tissue diseases and psychosis
	(iv) Patients with heart, brain, lung, kidney, hemopoietic system and endocrine system primary diseases
	(v) Patients with abdominal operation
	(vi) Patients with renal insufficiency, score of creatinine more than upper limit of normal
	(vii) Patients with hypohepatia, score of alanine aminotransferase ≥1.5 × upper limit of normal
	(viii) Current pregnancy or lactation
	(ix) Psychopaths and disability in law
	(x) Patients participated in another clinic trial in past 3 months